Open Access
Polymeric micellar nanoparticles for effective CRISPR/Cas9 genome editing in cancer
Yuzhen Li
1
,
Yuzhen Li
1, 2
,
Chun Li
1
,
Chun Li
1, 2
,
Jiachang Yan
1, 2
,
Ying Liao
3
,
Chao Qin
1
,
Chengyuan Qin
1, 2
,
Long Wang
1
,
Lingyin Wang
1, 2
,
Yi Huang
1, 2
,
Chuan Yang
4
,
Jianwei Wang
3
,
Xianfeng Ding
4
,
Xin Ding
4
,
Yi-Yan Yang
5
,
Peiyan Yuan
1, 2
Publication type: Journal Article
Publication date: 2024-09-01
scimago Q1
wos Q1
SJR: 2.998
CiteScore: 28.5
Impact factor: 12.9
ISSN: 01429612, 18785905
PubMed ID:
38677222
Abstract
The clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein 9 (Cas9) gene editing has attracted extensive attentions in various fields, however, its clinical application is hindered by the lack of effective and safe delivery system. Herein, we reported a cationic micelle nanoparticle composed of cholesterol-modified branched small molecular PEI (PEI-CHO) and biodegradable PEG-b-polycarbonate block copolymer (PEG-PC), denoted as PEG-PC/PEI-CHO/pCas9, for the CRISPR/Cas9 delivery to realize genomic editing in cancer. Specifically, PEI-CHO condensed pCas9 into nanocomplexes, which were further encapsulated into PEG-PC nanoparticles (PEG-PC/PEI-CHO/pCas9). PEG-PC/PEI-CHO/pCas9 had a PEG shell, protecting DNA from degradation by nucleases. Enhanced cellular uptake of PEG-PC/PEI-CHO/pCas9 nanoparticles was observed as compared to that mediated by Lipo2k/pCas9 nanoparticles, thus leading to significantly elevated transfection efficiency after escaping from endosomes via the proton sponge effect of PEI. In addition, the presence of PEG shell greatly improved biocompatibility, and significantly enhanced the in vivo tumor retention of pCas9 compared to PEI-CHO/pCas9. Notably, apparent downregulation of GFP expression could be achieved both in vitro and in vivo by using PEG-PC/PEI-CHO/pCas9-sgGFP nanoparticles. Furthermore, PEG-PC/PEI-CHO/pCas9-sgMcl1 induced effective apoptosis and tumor suppression in a HeLa tumor xenograft mouse model by downregulating Mcl1 expression. This work may provide an alternative paradigm for the efficient and safe genome editing in cancer.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
|
|
|
FEBS Letters
1 publication, 5%
|
|
|
Journal of Functional Biomaterials
1 publication, 5%
|
|
|
Russian Chemical Reviews
1 publication, 5%
|
|
|
ACS applied materials & interfaces
1 publication, 5%
|
|
|
3 Biotech
1 publication, 5%
|
|
|
Oncology Letters
1 publication, 5%
|
|
|
Journal of Nanobiotechnology
1 publication, 5%
|
|
|
Frontiers in Medicine
1 publication, 5%
|
|
|
International Journal of Nanomedicine
1 publication, 5%
|
|
|
Advances in Colloid and Interface Science
1 publication, 5%
|
|
|
Journal of Colloid and Interface Science
1 publication, 5%
|
|
|
Journal of Industrial and Engineering Chemistry
1 publication, 5%
|
|
|
Molecular Pharmaceutics
1 publication, 5%
|
|
|
Chinese Science Bulletin (Chinese Version)
1 publication, 5%
|
|
|
Next Nanotechnology
1 publication, 5%
|
|
|
STAR Protocols
1 publication, 5%
|
|
|
Journal of Drug Delivery Science and Technology
1 publication, 5%
|
|
|
MicroRNA (Shariqah, United Arab Emirates)
1 publication, 5%
|
|
|
Precision Medicine and Engineering
1 publication, 5%
|
|
|
Acta Biomaterialia
1 publication, 5%
|
|
|
1
|
Publishers
|
1
2
3
4
5
6
7
8
|
|
|
Elsevier
8 publications, 40%
|
|
|
American Chemical Society (ACS)
2 publications, 10%
|
|
|
Springer Nature
2 publications, 10%
|
|
|
Wiley
1 publication, 5%
|
|
|
MDPI
1 publication, 5%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 5%
|
|
|
Spandidos Publications
1 publication, 5%
|
|
|
Frontiers Media S.A.
1 publication, 5%
|
|
|
Taylor & Francis
1 publication, 5%
|
|
|
Science in China Press
1 publication, 5%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 5%
|
|
|
1
2
3
4
5
6
7
8
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
20
Total citations:
20
Citations from 2024:
20
(100%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Li Y. et al. Polymeric micellar nanoparticles for effective CRISPR/Cas9 genome editing in cancer // Biomaterials. 2024. Vol. 309. p. 122573.
GOST all authors (up to 50)
Copy
Li Y., Li Y., Li C., Li C., Yan J., Liao Y., Qin C., Qin C., Wang L., Wang L., Huang Y., Yang C., Wang J., Ding X., Ding X., Yang Y., Yuan P. Polymeric micellar nanoparticles for effective CRISPR/Cas9 genome editing in cancer // Biomaterials. 2024. Vol. 309. p. 122573.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.biomaterials.2024.122573
UR - https://linkinghub.elsevier.com/retrieve/pii/S0142961224001078
TI - Polymeric micellar nanoparticles for effective CRISPR/Cas9 genome editing in cancer
T2 - Biomaterials
AU - Li, Yuzhen
AU - Li, Yuzhen
AU - Li, Chun
AU - Li, Chun
AU - Yan, Jiachang
AU - Liao, Ying
AU - Qin, Chao
AU - Qin, Chengyuan
AU - Wang, Long
AU - Wang, Lingyin
AU - Huang, Yi
AU - Yang, Chuan
AU - Wang, Jianwei
AU - Ding, Xianfeng
AU - Ding, Xin
AU - Yang, Yi-Yan
AU - Yuan, Peiyan
PY - 2024
DA - 2024/09/01
PB - Elsevier
SP - 122573
VL - 309
PMID - 38677222
SN - 0142-9612
SN - 1878-5905
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2024_Li,
author = {Yuzhen Li and Yuzhen Li and Chun Li and Chun Li and Jiachang Yan and Ying Liao and Chao Qin and Chengyuan Qin and Long Wang and Lingyin Wang and Yi Huang and Chuan Yang and Jianwei Wang and Xianfeng Ding and Xin Ding and Yi-Yan Yang and Peiyan Yuan},
title = {Polymeric micellar nanoparticles for effective CRISPR/Cas9 genome editing in cancer},
journal = {Biomaterials},
year = {2024},
volume = {309},
publisher = {Elsevier},
month = {sep},
url = {https://linkinghub.elsevier.com/retrieve/pii/S0142961224001078},
pages = {122573},
doi = {10.1016/j.biomaterials.2024.122573}
}